Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™)

Published:2016-01-06 Issue:1 Volume:94 Page:93-98
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Goswami Rama P.,Satpati Aditya,Das Sukhen,Goswami Rudra P.,Rahman Mehebubar

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference26 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

2. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India;Singh;Trop Med Int Health,2006

3. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study;Sundar;Clin Infect Dis,2003

4. Liposomal amphotericin B for the treatment of visceral leishmaniasis;Bern;Clin Infect Dis,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review;Frontiers in Bioengineering and Biotechnology;2022-12-14

2. The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses;Virulence;2022-05-30

3. Trendings of amphotericin B-loaded nanoparticles as valuable chemotherapeutic approaches against leishmaniasis;Applications of Nanobiotechnology for Neglected Tropical Diseases;2021

4. Combination Therapy Against Indian Visceral Leishmaniasis with Liposomal Amphotericin B (FungisomeTM) and Short-Course Miltefosine in Comparison to Miltefosine Monotherapy;The American Journal of Tropical Medicine and Hygiene;2020-07-08

5. Adverse reactions to meglumine antimoniate in Brazilian inpatients with visceral leishmaniases: A case series;Journal of Clinical Pharmacy and Therapeutics;2019-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3